How Are Competitors Faring? Intel faces strong competition from NVIDIA Corporation (NVDA) and Advanced Micro Devices (AMD) in this space. NVIDIA boasts a strong expertise in AI training, AI inference and dominates in generative AI deployments. The company is also rapidly expanding its sovereign AI stack. By combining NVIDIA AI platforms with domestic AI capabilities of each nation, the company aims to build robust and secure domestic AI ecosystems tailored to each nation's unique requirements. Key Takeaways ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Erasca To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Erasca between January 14, 2025 and April 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information]New York, New York--(Newsfile Corp. - June 24, 2026) - ...

Majestic Gold Corp. is a low-cost junior gold producer engaged in commercial gold production in eastern Shandong Province, China, with mining operations at its Songjiagou Gold Mines and the Mujin Gold Project. Additional information on the Company and its projects is available at www.sedarplus.ca and on the Company's website at www.majesticgold.com. For further information, please contact: James Mackie, Chief Financial Officer & Corporate Secretary Telephone: (604) 560-9060 Email: info@majesticgold.com Webs ...

Shares of Arm Holdings continued to decline on Wednesday, extending losses after the semiconductor stock tumbled more than 10% in the previous session as investors rotated out of several high-flying artificial intelligence names. Arm shares fell 4.7% to $349.03 and are down about 19% since the beginning of the week. ...

Micron Price Prediction: The Forecast Flags a Big Pullback - 24/7 Wall St. S&P 5007,378.40 -0.30% Dow Jones51,983.40 +0.25% Nasdaq 10029,276.00 -0.86% Russell 20002,992.61 +0.35% FTSE 10010,456.80 -0.05% Nikkei 22569,189.70 -0.19% Stock Market Live June 24, 2026: S&P 500 (SPY) Attempting to Regain Momentum Investing Micron Price Prediction: The Forecast Flags a Big Pullback How to Add Us to Google News By Vandita Jadeja Published Jun 24, 2:14PM EDT Quick Read Micron (MU) trades near $1,052 but our model fla ...

核心观点 - 精准医学公司Natera的Signatera检测产品获得日本监管批准，计划于2026年底前在日本商业化，这是其国际肿瘤业务扩张的关键里程碑 [1] - 日本每年有超过15万人被诊断出结直肠癌，是该国最常见的癌症之一，凸显了对个性化治疗策略的需求 [1] 产品与市场 - 产品Signatera是一种用于肌肉浸润性膀胱癌的循环肿瘤DNA检测技术，近期获得了美国国家综合癌症网络指南的认可 [4] - 这是ctDNA检测第三次获得NCCN指南推荐，可能改善患者治疗方案，并对公司的市场地位和增长潜力产生积极影响 [5] 临床证据 - GALAXY临床试验的结果支持了此次监管批准，该试验分析了2240个样本，是评估可切除结直肠癌MRD检测的最大规模前瞻性研究之一 [2] - 研究显示，术后MRD检测呈阳性的患者从辅助化疗中获益显著，而MRD阴性患者则未显示出获益 [2] - 该研究是更广泛的CIRCULATE-Japan平台的一部分，该平台涉及日本数千名患者和超过150家机构 [3] 商业化与合作伙伴 - 日本最大的参考实验室SRL Inc将主导Signatera在日本的商业化推广，该公司是H U Group Holdings的成员 [4] - SRL作为Natera在日本的独家商业伙伴，将通过其全国实验室网络帮助扩大个性化MRD检测的可及性 [4] 市场反应 - 消息发布后，Natera股价在周三上涨10.29%，至258.92美元 [5]

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Embecta To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Embecta between November 25, 2025 and May 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).[You may also click here for additional information]New York, New York--(Newsfile Corp. - June 24, 2026) - F ...

核心观点 - 尽管公司5月及年初至今的汽车交付量实现显著增长，但公司股价近期仍处于下跌趋势，主要受到技术面疲软及美国前政府将其列为“中国军事公司”带来的不确定性影响 [2] 股价表现与近期趋势 - 公司股价自5月峰值已下跌近30%，进入局部熊市阶段 [2] - 截至发稿时，公司股价下跌2.55%至4.96美元 [9] - 股价正试图在5美元区域附近企稳，该区域与一条上升的周趋势线对齐，可能吸引逢低买入者，但若失守也可能引发硬性破位 [3] 技术指标分析 - 从趋势角度看，公司股价处于修复阶段：当前4.97美元的价格低于20日简单移动平均线（5.37美元）7.5%，低于50日简单移动平均线（5.83美元）14.7% [4] - 20日简单移动平均线位于50日简单移动平均线之下，这强化了短期反弹可能迅速消退的观点，除非价格能重新站上该均线带 [4] - MACD指标目前位于其信号线之下，且直方图为负值，表明相较于之前的上升势头，上行压力正在冷却 [5] - 长期图表更为复杂，50日简单移动平均线仍高于200日简单移动平均线（4月形成金叉），但价格未能维持在长期趋势指标之上 [6] 关键价格水平 - 关键阻力位：6.00美元，该整数关口也与50日移动平均线区域接近，反弹可能在此停滞 [9] - 关键支撑位：5.00美元，该附近的整数关口正充当当前的“底线”区域 [9] 公司业务概况 - 公司是中国一家针对高端市场的领先电动汽车制造商，成立于2014年11月，设计、开发、联合制造和销售高端智能电动汽车，并以换电和自动驾驶等技术作为差异化卖点 [7] - 公司于2017年12月推出首款车型ES8七座电动SUV，并于2018年6月开始交付，目前产品组合涵盖中型至大型轿车和SUV [8] - 公司在2025年销售了约326，000辆电动汽车，约占中国乘用新能源车市场的2% [8] 运营与市场动态 - 公司5月交付量同比增长62.3%至37，705辆，年初至今交付量增长68.7%至150，526辆 [2] - 公司股价交易通常处于交付势头、中国消费者需求以及多变的美中政策头条新闻的交汇点 [8] 外部风险事件 - 美国前政府将公司列为“中国军事公司”，公司称此认定“不合理”，并计划与美国国防部接洽，必要时可能采取法律行动，这增加了市场不确定性 [2]

行业表现与市场动态 - iShares美国住宅建筑ETF进入新的牛市，自5月19日以来上涨21%，并在周三交易中再涨5% [3] - 投资者涌入与住房相关的股票，推动了此次上涨 [3]

The market has had ample opportunity to adjust to the reality that interest rates will remain elevated for a prolonged period. The critical detail with KB Home is that it has repositioned itself as a built-to-order specialist capable of sustaining positive cash flows in all cycles. Get KB Home alerts: KB Home NYSE: KBH is not out of the weeds, with its revenue contracting, orders and backlog declining, and margins under pressure, but these forces are already priced into its stock. Housing market woes, infla ...